Navigation Links
Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee
Date:11/19/2008

h companies outside of the human therapeutic space including Dow AgroSciences, Sigma-Aldrich Corporation and several companies applying its ZFP technology to enhance the production of protein pharmaceuticals. For more information about Sangamo, visit the company's web site at http://www.sangamo.com.

This press release contains forward-looking statements regarding Sangamo's current expectations. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include the early stage of ZFP Therapeutic development, uncertainties related to the timing of initiation and completion of clinical trials, and whether clinical trial results will validate and support the safety and efficacy of ZFP Therapeutics. Further, there can be no assurance that the necessary regulatory approvals will be obtained or that Sangamo will be able to develop commercially viable therapeutics. Actual results may differ from those projected in forward-looking statements due to risks and uncertainties that exist in Sangamo's operations and business environments. These risks and uncertainties are described more fully in Sangamo's' Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q as filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and will not be updated.


'/>"/>
SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
2. Sangamo BioSciences Reports Third Quarter 2008 Financial Results
3. Sangamo BioSciences Presents Data at ICAAC Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
4. Sangamo BioSciences Announces Third Quarter Conference Call and Webcast
5. Sangamo BioSciences to Present at Two Upcoming Investor Conferences
6. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
7. Sangamo BioSciences to Present at the Canaccord Adams Global Growth Conference
8. Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
9. Sangamo BioSciences Reports Second Quarter 2008 Financial Results
10. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
11. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ( SVA),...ounced today that it executed,a joint venture (JV)...echnology Co., Ltd. (Sinovac Dalian). The JV will ...-use vaccines. Sinovac will contribute its experti...g world-class vaccines; the,other party will bring...
(Date:11/25/2009)...wire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq...rm.D., president and chief executive officer, will...are Conference. , ,Presentation details are as fo...erence,Date: Tuesday, December 1, 2009,Time: ...k Palace Hotel, New York, NY,Webcast: <a href=,...
(Date:11/24/2009)...swire-FirstCall/ -- IES (Nasdaq: IESC ), a leadin...ns systems and services for the commercial, indust... its commercial business group has been awarded a ...lectrical systems for the Level 4 bio-safety lab (...al Research Institute of Infectious Diseases (USAM...
(Date:11/24/2009)...investment bank KTA Capital,s client Neuren Pharma...onvertible note private placement with a U.S. inst...nged by KTA Capital as Neuren,s exclusive placemen...w York (PRWEB) November 23, 2009 -- The independen...;KTA Capital") has announced that its client ...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
... ExonHit Therapeutics, a,drug and diagnostic disco...st blood-based Alzheimer,s disease test. The compa...ide it as a service in its GLP (Good,Laboratory Pr...cal industry,as early as 2009. This initial ExonH...lzheimer,s disease from a simple blood sample. Fur...
...Are Among The Organizations Advocating Use of Hand...and Protection, NORCROSS, Ga., Nov. 8 Headlines ...ureus) deadlier than AIDS, and the media continue,...the most extreme cases,student deaths due to this ...washing is advocated as one of the best means of p...
... Nov. 8 Ortho Biotech,Products, L.P. today modifi... alfa), following guidance from the U.S. Food and ...ll drugs within the,erythropoiesis-stimulating age...e based on previously reported data,and include re...s Advisory,Committee meeting, and the September 11...
Other Biology Technology:ExonHit Completes a Prototype to Detect Alzheimer's Disease From Blood 2ExonHit Completes a Prototype to Detect Alzheimer's Disease From Blood 3ExonHit Completes a Prototype to Detect Alzheimer's Disease From Blood 4Soap and Water May not be Enough to Fight MRSA Superbug 2Soap and Water May not be Enough to Fight MRSA Superbug 3Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) Label Reflects Recommendations from Recent FDA Advisory Committee Meetings 2Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) Label Reflects Recommendations from Recent FDA Advisory Committee Meetings 3Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) Label Reflects Recommendations from Recent FDA Advisory Committee Meetings 4Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) Label Reflects Recommendations from Recent FDA Advisory Committee Meetings 5
(Date:11/30/2009)...ajor obstacle to HIV research is the virus,s exqui...at scientists, traditional tools, like the humble ...ow, a team of researchers writing in BioMed Centra...ingenious assault on this problem by creating a mo... being infected with HIV. , George Kassiotis, fr...
(Date:11/30/2009)... , VILNIUS, Lithuania, Nov. 30 /PRNewsw...gy.com ), a provider of high-precision biometric i...pgrades in the company,s core product line: VeriL... recognition and MegaMatcher 3.1 SDK for large-s...ntification systems (AFIS). Expanded capabilities ...
(Date:11/26/2009)...zed for their impressive antlers, red deer have be...But a deer,s antlers are much more than decorative...r when duelling. John Currey, from The University ...properties of bone for over half a century and has... antler through a long-standing collaboration with...
Breaking Biology News(10 mins):A reductionist approach to HIV research 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3Tough yet stiff deer antler is materials scientist's dream 2General anesthetics lead to learning disabilities in animal models 59954 1General anesthetics lead to learning disabilities in animal models 59954 2General anesthetics lead to learning disabilities in animal models 59954 3Extra care for outwardly healthy workers costs companies millions annually 59951 1Extra care for outwardly healthy workers costs companies millions annually 59951 2Nanowire biocompatibility in the brain 3A So far so good 10481 1Nanowire biocompatibility in the brain 3A So far so good 10481 2
...Lotions and potions that promise to remove wrinkle... shelves, but do these treatments really work? , V...have identified new molecular indicators -- or "bi...ed to evaluate anti-aging therapies. Their finding...l of Investigative Dermatology. , "There,s a lot ...
...Attaching a recently discovered cytokine to neural...at Cedars-Sinai Medical Center,s Maxine Dunitz Neu...k and kill malignant brain tumor cells and provide...lts of an animal study are published in the March ...ers are now applying to regulatory agencies to tra...
...A new study on identifying which patients were lik... liver transplant (LDLT) found that measuring how ...r shortly after surgery was an accurate indicator ...tor of the outcome of the procedure. The study use... making it particularly useful in treating transpl...
Other Biology News:Biomarkers may hone anti-aging therapies 2Marrow-derived stem cells deliver new cytokine to kill brain tumor cells, offer protection 2Marrow-derived stem cells deliver new cytokine to kill brain tumor cells, offer protection 3Predicting successful outcomes in living-donor liver transplants 2Predicting successful outcomes in living-donor liver transplants 3
...ot automates LC micro-fractionation, spotting and ...tem, LC eluent can be accurately and continuously ... allows for automatic preparation of target plates...nction with Shimadzus Two-Dimensional Micro LC Sys...
...-Jun NH2-terminal kinase) signal transduction casc... in mammals. JNK pathway activation occurs in resp...he nuclear accumulation of JNK itself, and is impl...ion, oncogenic transformation, morphogenesis, and ...
HP GenomeWide siRNA from QIAGEN
...Screen cDNA Library Panels were designed for full-... PCRs to identify the desired cDNA clone. The firs...late," where each well contains plasmid DNA from 5...) by gel electrophoresis of the reaction products,...
Biology Products: